Fig. 6From: Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancerInternal validation of the risk score in the TCGA and GSE84437 cohort. A, B The Kaplan–Meier survival analysis and the time-dependent ROC analysis of the signature for predicting the OS of patients in the TCGA cohort. C, D The Kaplan–Meier survival analysis and the time-dependent ROC analysis of the signature for predicting the OS of patients in the GSE84437 cohortBack to article page